Poongjeon Pharmacy to conduct ₩3B third-party allotment rights offering
Predicted impact: Medium
₩3B third-party rights offering is about 14% of market value, well above 5% threshold.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.